Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 250

The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.

Mechanisms and pathology of protein misfolding and aggregation

Open access
Louros, Nikolaos, Schymkowitz, Joost, Rousseau, Frederic · 2023 · Nature Reviews Molecular Cell Biology

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41580-023-00647-2

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 53 references

Research works printed but not linked: 351

  1. Stroo, E., Koopman, M., Nollen, E. A. A. & Mata-Cabana, A. Cellular regulation of amyloid formation in aging and disease. Front. Neurosci. https://doi.org/10.3389/fnins.2017.00064 (2017). · DOI
  2. Hartl, F. U. Protein misfolding diseases. Annu. Rev. Biochem. 86, 21–26 (2017). · DOI · Paper page
  3. Buxbaum, J. N. et al. Amyloid nomenclature 2022: update, novel proteins, and recommendations by the International Society of Amyloidosis (ISA) Nomenclature Committee. Amyloid 29, 213–219 (2022). · DOI · Paper page
  4. Wechalekar, A. D., Gillmore, J. D. & Hawkins, P. N. Systemic amyloidosis. Lancet 387, 2641–2654 (2016). · DOI · Paper page
  5. Scheckel, C. & Aguzzi, A. Prions, prionoids and protein misfolding disorders. Nat. Rev. Genet. 19, 405–418 (2018). · DOI · Paper page
  6. Otzen, D. & Riek, R. Functional amyloids. Cold Spring Harb. Perspect. Biol. https://doi.org/10.1101/cshperspect.a033860 (2019). · DOI · Paper page
  7. Cereghetti, G. et al. Reversible amyloids of pyruvate kinase couple cell metabolism and stress granule disassembly. Nat. Cell Biol. 23, 1085–1094 (2021). · DOI
  8. Jeon, J., Yau, W.-M. & Tycko, R. Early events in amyloid-β self-assembly probed by time-resolved solid state NMR and light scattering. Nat. Commun. 14, 2964 (2023). · DOI
  9. Zimmermann, M. R. et al. Mechanism of secondary nucleation at the single fibril level from direct observations of Aβ42 aggregation. J. Am. Chem. Soc. 143, 16621–16629 (2021). · DOI
  10. Tracy, T. E. et al. Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration. Cell https://doi.org/10.1016/j.cell.2021.12.041 (2022). · DOI · Paper page
  11. Ferrari, L. et al. Arginine π-stacking drives binding to fibrils of the Alzheimer protein Tau. Nat. Commun. 11, 571 (2020). · DOI
  12. Gallardo, R., Ranson, N. A. & Radford, S. E. Amyloid structures: much more than just a cross-β fold. Curr. Opin. Struct. Biol. 60, 7–16 (2020). · DOI · Paper page
  13. Sawaya, M. R., Hughes, M. P., Rodriguez, J. A., Riek, R. & Eisenberg, D. S. The expanding amyloid family: structure, stability, function, and pathogenesis. Cell 184, 4857–4873 (2021). · DOI · Paper page
  14. Louros, N., van der Kant, R., Schymkowitz, J. & Rousseau, F. StAmP-DB: a platform for structures of polymorphic amyloid fibril cores. Bioinformatics 38, 2636–2638 (2022). · DOI
  15. van der Kant, R., Louros, N., Schymkowitz, J. & Rousseau, F. Thermodynamic analysis of amyloid fibril structures reveals a common framework for stability in amyloid polymorphs. Structure https://doi.org/10.1016/j.str.2022.05.002 (2022). · DOI
  16. Mullapudi, V. et al. Network of hotspot interactions cluster tau amyloid folds. Nat. Commun. 14, 895 (2023). · DOI
  17. Karplus, M. & Weaver, D. L. Protein-folding dynamics. Nature 260, 404–406 (1976). · DOI · Paper page
  18. Levinthal, C. Are there pathways for protein folding ? J. Chim. Phys. 65, 44–45 (1968). · DOI · Paper page
  19. Ellis, R. J. Protein folding: importance of the Anfinsen cage. Curr. Biol. 13, R881–883 (2003). · DOI
  20. Fersht, A. R. & Daggett, V. Protein folding and unfolding at atomic resolution. Cell 108, 573–582 (2002). · DOI · Paper page
  21. Kiefhaber, T. Kinetic traps in lysozyme folding. Proc. Natl Acad. Sci. USA 92, 9029–9033 (1995). · DOI · Paper page
  22. Silow, M. & Oliveberg, M. Transient aggregates in protein folding are easily mistaken for folding intermediates. Proc. Natl Acad. Sci. USA 94, 6084–6086 (1997). · DOI · Paper page
  23. Buchner, J. Molecular chaperones and protein quality control: an introduction to the JBC Reviews thematic series. J. Biol. Chem. 294, 2074–2075 (2019). · DOI
  24. Baldwin, A. J. et al. Metastability of native proteins and the phenomenon of amyloid formation. J. Am. Chem. Soc. 133, 14160–14163 (2011). · DOI · Paper page
  25. Chiti, F. et al. Kinetic partitioning of protein folding and aggregation. Nat. Struct. Biol. 9, 137–143 (2002). · DOI · Paper page
  26. Huang, C. et al. Intrinsically aggregation-prone proteins form amyloid-like aggregates and contribute to tissue aging in Caenorhabditis elegans. eLife https://doi.org/10.7554/eLife.43059 (2019). · DOI
  27. Vecchi, G. et al. Proteome-wide observation of the phenomenon of life on the edge of solubility. Proc. Natl Acad. Sci. USA 117, 1015–1020 (2020). · DOI
  28. Ciryam, P., Kundra, R., Morimoto, R. I., Dobson, C. M. & Vendruscolo, M. Supersaturation is a major driving force for protein aggregation in neurodegenerative diseases. Trends Pharmacol. Sci. 36, 72–77 (2015). · DOI · Paper page
  29. Ciryam, P. et al. A metastable subproteome underlies inclusion formation in muscle proteinopathies. Acta Neuropathol. Commun. https://doi.org/10.1186/s40478-019-0853-9 (2019). · DOI
  30. Niwa, T., Kanamori, T., Ueda, T. & Taguchi, H. Global analysis of chaperone effects using a reconstituted cell-free translation system. Proc. Natl Acad. Sci. USA 109, 8937–8942 (2012). · DOI · Paper page
  31. Fujiwara, K., Ishihama, Y., Nakahigashi, K., Soga, T. & Taguchi, H. A systematic survey of in vivo obligate chaperonin-dependent substrates. EMBO J. 29, 1552–1564 (2010). · DOI · Paper page
  32. Niwa, T., Fujiwara, K. & Taguchi, H. Identification of novel in vivo obligate GroEL/ES substrates based on data from a cell-free proteomics approach. FEBS Lett. 590, 251–257 (2016). · DOI
  33. Gestaut, D. et al. Structural visualization of the tubulin folding pathway directed by human chaperonin TRiC/CCT. Cell 185, 4770–4787.e20 (2022). · DOI
  34. Chen, D. H. et al. Visualizing GroEL/ES in the act of encapsulating a folding protein. Cell 153, 1354–1365 (2013). · DOI
  35. Sharma, S. et al. Monitoring protein conformation along the pathway of chaperonin-assisted folding. Cell 133, 142–153 (2008). · DOI · Paper page
  36. Ellis, R. J. Revisiting the Anfinsen cage. Fold. Des. 1, R9–R15 (1996). · DOI
  37. Sawaya, M. R. et al. Atomic structures of amyloid cross-β spines reveal varied steric zippers. Nature 447, 453–457 (2007). · DOI · Paper page
  38. Teng, P. K. & Eisenberg, D. Short protein segments can drive a non-fibrillizing protein into the amyloid state. Protein Eng. Des. Sel. 22, 531–536 (2009). · DOI
  39. Louros, N. et al. WALTZ-DB 2.0: an updated database containing structural information of experimentally determined amyloid-forming peptides. Nucleic Acids Res. 48, D389–D393 (2020). · DOI
  40. Santos, J., Pallares, I., Iglesias, V. & Ventura, S. Cryptic amyloidogenic regions in intrinsically disordered proteins: function and disease association. Comput. Struct. Biotechnol. J. 19, 4192–4206 (2021). · DOI
  41. Fuxreiter, M. Fold or not to fold upon binding—does it really matter? Curr. Opin. Struct. Biol. 54, 19–25 (2019). · DOI
  42. Oldfield, C. J. & Dunker, A. K. Intrinsically disordered proteins and intrinsically disordered protein regions. Annu. Rev. Biochem. 83, 553–584 (2014). · DOI · Paper page
  43. Maurer-Stroh, S. et al. Exploring the sequence determinants of amyloid structure using position-specific scoring matrices. Nat. Methods 7, 237–242 (2010). · DOI · Paper page
  44. Louros, N., Orlando, G., De Vleeschouwer, M., Rousseau, F. & Schymkowitz, J. Structure-based machine-guided mapping of amyloid sequence space reveals uncharted sequence clusters with higher solubilities. Nat. Commun. 11, 3314 (2020). · DOI
  45. Ulamec, S. M., Brockwell, D. J. & Radford, S. E. Looking beyond the core: the role of flanking regions in the aggregation of amyloidogenic peptides and proteins. Front. Neurosci. 14, 611285 (2020). · DOI
  46. Strodel, B. Energy landscapes of protein aggregation and conformation switching in intrinsically disordered proteins. J. Mol. Biol. 433, 167182 (2021). · DOI
  47. Mirbaha, H. et al. Inert and seed-competent tau monomers suggest structural origins of aggregation. eLife 7, e36584 (2018). · DOI · Paper page
  48. Furukawa, K. et al. Isoelectric point-amyloid formation of α-synuclein extends the generality of the solubility and supersaturation-limited mechanism. Curr. Res. Struct. Biol. 2, 35–44 (2020). · DOI
  49. Kandola, T. et al. The polyglutamine amyloid nucleus in living cells is a monomer with competing dimensions of order. Preprint at bioRxiv https://doi.org/10.1101/2021.08.29.458132 (2021). · DOI
  50. Killinger, B. A., Melki, R., Brundin, P. & Kordower, J. H. Endogenous α-synuclein monomers, oligomers and resulting pathology: let’s talk about the lipids in the room. NPJ Parkinsons Dis. 5, 23 (2019). · DOI
  51. Sciacca, M. F. et al. Lipid-chaperone hypothesis: a common molecular mechanism of membrane disruption by intrinsically disordered proteins. ACS Chem. Neurosci. 11, 4336–4350 (2020). · DOI
  52. Riback, J. A. et al. Innovative scattering analysis shows that hydrophobic disordered proteins are expanded in water. Science 358, 238–241 (2017). · DOI · Paper page
  53. Borgia, A. et al. Transient misfolding dominates multidomain protein folding. Nat. Commun. 6, 8861 (2015). · DOI
  54. Borgia, M. B. et al. Single-molecule fluorescence reveals sequence-specific misfolding in multidomain proteins. Nature 474, 662–665 (2011). · DOI · Paper page
  55. Zheng, W., Schafer, N. P. & Wolynes, P. G. Frustration in the energy landscapes of multidomain protein misfolding. Proc. Natl Acad. Sci. USA 110, 1680–1685 (2013). · DOI
  56. Guthertz, N. et al. The effect of mutation on an aggregation-prone protein: an in vivo, in vitro, and in silico analysis. Proc. Natl Acad. Sci. USA 119, e2200468119 (2022). · DOI
  57. Ventura, S. et al. Short amino acid stretches can mediate amyloid formation in globular proteins: the Src homology 3 (SH3) case. Proc. Natl Acad. Sci. USA 101, 7258–7263 (2004). · DOI · Paper page
  58. Ivanova, M. I., Sawaya, M. R., Gingery, M., Attinger, A. & Eisenberg, D. An amyloid-forming segment of β2-microglobulin suggests a molecular model for the fibril. Proc. Natl Acad. Sci. USA 101, 10584–10589 (2004). · DOI · Paper page
  59. Ventura, S., Lacroix, E. & Serrano, L. Insights into the origin of the tendency of the PI3–SH3 domain to form amyloid fibrils. J. Mol. Biol. 322, 1147–1158 (2002). · doi:10.1016/s0022-2836(02)00783-0
  60. Michiels, E. et al. Reverse engineering synthetic antiviral amyloids. Nat. Commun. 11, 2832 (2020). · DOI
  61. Khodaparast, L. et al. Aggregating sequences that occur in many proteins constitute weak spots of bacterial proteostasis. Nat. Commun. 9, 866 (2018). · DOI
  62. Gallardo, R. et al. De novo design of a biologically active amyloid. Science https://doi.org/10.1126/science.aah4949 (2016). · DOI
  63. De Baets, G., Van Doorn, L., Rousseau, F. & Schymkowitz, J. Increased aggregation is more frequently associated to human disease-associated mutations than to neutral polymorphisms. PLoS Comput. Biol. 11, e1004374 (2015). · DOI
  64. Thangakani, A. M., Kumar, S., Velmurugan, D. & Gromiha, M. S. M. How do thermophilic proteins resist aggregation. Proteins Struct. Funct. Bioinforma. 80, 1003–1015 (2012). · DOI
  65. Langenberg, T. et al. Thermodynamic and evolutionary coupling between the native and amyloid state of globular proteins. Cell Rep. 31, 107512 (2020). · DOI
  66. Geller, R., Pechmann, S., Acevedo, A., Andino, R. & Frydman, J. Hsp90 shapes protein and RNA evolution to balance trade-offs between protein stability and aggregation. Nat. Commun. 9, 1781 (2018). · DOI
  67. Claes, F. et al. Exposure of a cryptic Hsp70 binding site determines the cytotoxicity of the ALS-associated SOD1-mutant A4V. Protein Eng. Des. Sel. 32, 443–457 (2019). · DOI
  68. Gilis, D., Massar, S., Cerf, N. J. & Rooman, M. Optimality of the genetic code with respect to protein stability and amino-acid frequencies. Genome Biol. 2, RESEARCH0049 (2001). · DOI · Paper page
  69. Buck, P. M., Kumar, S. & Singh, S. K. On the role of aggregation prone regions in protein evolution, stability, and enzymatic catalysis: insights from diverse analyses. PLoS Comput. Biol. 9, e1003291 (2013). · DOI
  70. Maury, C. P. Self-propagating β-sheet polypeptide structures as prebiotic informational molecular entities: the amyloid world. Orig. Life Evol. Biosph. 39, 141–150 (2009). · DOI
  71. Carny, O. & Gazit, E. A model for the role of short self-assembled peptides in the very early stages of the origin of life. FASEB J. 19, 1051–1055 (2005). · DOI
  72. Rout, S. K., Rhyner, D., Riek, R. & Greenwald, J. Prebiotically plausible autocatalytic peptide amyloids. Chemistry 28, e202103841 (2022). · DOI
  73. Serio, T. R. et al. Nucleated conformational conversion and the replication of conformational information by a prion determinant. Science 289, 1317–1321 (2000). · DOI · Paper page
  74. Carny, O. & Gazit, E. Creating prebiotic sanctuary: self-assembling supramolecular peptide structures bind and stabilize RNA. Orig. Life Evol. Biosph. 41, 121–132 (2011). · DOI
  75. Sanderson, J. M. The association of lipids with amyloid fibrils. J. Biol. Chem. 298, 102108 (2022). · DOI
  76. Rufo, C. M. et al. Short peptides self-assemble to produce catalytic amyloids. Nat. Chem. 6, 303–309 (2014). · DOI · Paper page
  77. Sun-Wang, J. L., Ivanova, S. & Zorzano, A. The dialogue between the ubiquitin-proteasome system and autophagy: implications in ageing. Ageing Res. Rev. 64, 101203 (2020). · DOI
  78. Balchin, D., Hayer-Hartl, M. & Hartl, F. U. Recent advances in understanding catalysis of protein folding by molecular chaperones. FEBS Lett. 594, 2770–2781 (2020). · DOI · Paper page
  79. Mashaghi, A. et al. Alternative modes of client binding enable functional plasticity of Hsp70. Nature 539, 448–451 (2016). · DOI · Paper page
  80. Faust, O. et al. HSP40 proteins use class-specific regulation to drive HSP70 functional diversity. Nature 587, 489–494 (2020). · DOI · Paper page
  81. Goloubinoff, P., Sassi, A. S., Fauvet, B., Barducci, A. & De Los Rios, P. Chaperones convert the energy from ATP into the nonequilibrium stabilization of native proteins. Nat. Chem. Biol. 14, 388–395 (2018). · DOI
  82. Kaushik, S. & Cuervo, A. M. The coming of age of chaperone-mediated autophagy. Nat. Rev. Mol. Cell Biol. 19, 365–381 (2018). · DOI · Paper page
  83. Xu, C. Y. et al. DJ-1 Inhibits α-synuclein aggregation by regulating chaperone-mediated autophagy. Front. Aging Neurosci. 9, 308 (2017). · DOI
  84. Baughman, H. E. R., Clouser, A. F., Klevit, R. E. & Nath, A. HspB1 and Hsc70 chaperones engage distinct tau species and have different inhibitory effects on amyloid formation. J. Biol. Chem. 293, 2687–2700 (2018). · DOI
  85. Kundel, F. et al. Hsp70 inhibits the nucleation and elongation of tau and sequesters tau aggregates with high affinity. ACS Chem. Biol. 13, 636–646 (2018). · DOI
  86. Avellaneda, M. J. et al. Processive extrusion of polypeptide loops by a Hsp100 disaggregase. Nature 578, 317–320 (2020). · DOI
  87. Nachman, E. et al. Disassembly of Tau fibrils by the human Hsp70 disaggregation machinery generates small seeding-competent species. J. Biol. Chem. 295, 9676–9690 (2020). · DOI · Paper page
  88. Wentink, A. S. et al. Molecular dissection of amyloid disaggregation by human HSP70. Nature 587, 483–488 (2020). · DOI · Paper page
  89. Stein, K. C. & Frydman, J. The stop-and-go traffic regulating protein biogenesis: how translation kinetics controls proteostasis. J. Biol. Chem. 294, 2076–2084 (2019). · DOI · Paper page
  90. Yan, X. W., Hoek, T. A., Vale, R. D. & Tanenbaum, M. E. Dynamics of translation of single mRNA molecules in vivo. Cell 165, 976–989 (2016). · DOI · Paper page
  91. Jacobs, W. M. & Shakhnovich, E. I. Evidence of evolutionary selection for cotranslational folding. Proc. Natl Acad. Sci. USA 114, 11434–11439 (2017). · DOI
  92. Bitran, A., Jacobs, W. M., Zhai, X. & Shakhnovich, E. Cotranslational folding allows misfolding-prone proteins to circumvent deep kinetic traps. Proc. Natl Acad. Sci. USA 117, 1485–1495 (2020). · DOI
  93. Zhou, T., Weems, M. & Wilke, C. O. Translationally optimal codons associate with structurally sensitive sites in proteins. Mol. Biol. Evol. 26, 1571–1580 (2009). · DOI · Paper page
  94. Doring, K. et al. Profiling Ssb-nascent chain interactions reveals principles of Hsp70-assisted folding. Cell 170, 298 (2017). · DOI · Paper page
  95. Stein, K. C., Morales-Polanco, F., van der Lienden, J., Rainbolt, T. K. & Frydman, J. Ageing exacerbates ribosome pausing to disrupt cotranslational proteostasis. Nature 601, 637–642 (2022). · DOI · Paper page
  96. Wruck, F. et al. The ribosome modulates folding inside the ribosomal exit tunnel. Commun. Biol. 4, 523 (2021). · DOI
  97. Shen, K. et al. Dual role of ribosome-binding domain of NAC as a potent suppressor of protein aggregation and aging-related proteinopathies. Mol. Cell 74, 729–741.e7 (2019). · DOI
  98. Rousseau, F., Serrano, L. & Schymkowitz, J. W. How evolutionary pressure against protein aggregation shaped chaperone specificity. J. Mol. Biol. 355, 1037–1047 (2006). · DOI · Paper page
  99. Monsellier, E. & Chiti, F. Prevention of amyloid-like aggregation as a driving force of protein evolution. EMBO Rep. 8, 737–742 (2007). · DOI · Paper page
  100. Houben, B. et al. Autonomous aggregation suppression by acidic residues explains why chaperones favour basic residues. EMBO J. https://doi.org/10.15252/embj.2019102864 (2020). · DOI
  101. Ganesan, A. et al. Structural hot spots for the solubility of globular proteins. Nat. Commun. 7, 10816 (2016). · DOI
  102. De Baets, G., Van Durme, J., Rousseau, F. & Schymkowitz, J. A genome-wide sequence-structure analysis suggests aggregation gatekeepers constitute an evolutionary constrained functional class. J. Mol. Biol. 426, 2405–2412 (2014). · DOI
  103. Casari, G., Sander, C. & Valencia, A. A method to predict functional residues in proteins. Nat. Struct. Biol. 2, 171–178 (1995). · DOI · Paper page
  104. Huang, L. et al. DAXX represents a new type of protein-folding enabler. Nature https://doi.org/10.1038/s41586-021-03824-5 (2021). · DOI
  105. Doherty, C. P. A. et al. A short motif in the N-terminal region of α-synuclein is critical for both aggregation and function. Nat. Struct. Mol. Biol. 27, 249 (2020). · DOI · Paper page
  106. Yoshimura, Y. et al. MOAG-4 promotes the aggregation of α-synuclein by competing with self-protective electrostatic interactions. J. Biol. Chem. 292, 8269–8278 (2017). · DOI
  107. van Ham, T. J. et al. Identification of MOAG-4/SERF as a regulator of age-related proteotoxicity. Cell 142, 601–612 (2010). · DOI · Paper page
  108. Pras, A. et al. The cellular modifier MOAG-4/SERF drives amyloid formation through charge complementation. EMBO J. 40, e107568 (2021). · DOI
  109. Hong, J.-Y. et al. Structural and dynamic studies reveal that the Ala-rich region of ataxin-7 initiates α-helix formation of the polyQ tract but suppresses its aggregation. Sci. Rep. 9, 7481 (2019). · DOI
  110. Chen, D. et al. Tau local structure shields an amyloid-forming motif and controls aggregation propensity. Nat. Commun. 10, 2493 (2019). · DOI · Paper page
  111. Zhang, W. et al. Modulation of the aggregation of an amyloidogenic sequence by flanking-disordered region in the intrinsically disordered antigen merozoite surface protein 2. Eur. Biophys. J. 48, 99–110 (2019). · DOI
  112. Santner, A. A. et al. Sweeping away protein aggregation with entropic bristles: intrinsically disordered protein fusions enhance soluble expression. Biochemistry 51, 7250–7262 (2012). · DOI
  113. Graña-Montes, R., Marinelli, P., Reverter, D. & Ventura, S. N-terminal protein tails act as aggregation protective entropic bristles: the SUMO case. Biomacromolecules 15, 1194–1203 (2014). · DOI
  114. Michiels, E. et al. Entropic bristles tune the seeding efficiency of prion-nucleating fragments. Cell Rep. 30, 2834–2845.e3 (2020). · DOI
  115. Housmans, J. A. J. et al. Investigating the sequence determinants of the curling of amyloid fibrils using ovalbumin as a case study. Biomacromolecules 23, 3779–3797 (2022). · DOI
  116. Iadanza, M. G., Jackson, M. P., Hewitt, E. W., Ranson, N. A. & Radford, S. E. A new era for understanding amyloid structures and disease. Nat. Rev. Mol. Cell Biol. 19, 755–773 (2018). · DOI · Paper page
  117. Dueholm, M. S. et al. Fibrillation of the major curli subunit CsgA under a wide range of conditions implies a robust design of aggregation. Biochemistry 50, 8281–8290 (2011). · DOI
  118. Bemporad, F., De Simone, A., Chiti, F. & Dobson, C. M. Characterizing intermolecular interactions that initiate native-like protein aggregation. Biophys. J. 102, 2595–2604 (2012). · DOI
  119. Lafita, A., Tian, P., Best, R. B. & Bateman, A. Tandem domain swapping: determinants of multidomain protein misfolding. Curr. Opin. Struct. Biol. 58, 97–104 (2019). · DOI
  120. Salinas, N. et al. The amphibian antimicrobial peptide uperin 3.5 is a cross-α/cross-β chameleon functional amyloid. Proc. Natl Acad. Sci. USA 118, e2014442118 (2021). · DOI
  121. Bowden, G. A., Paredes, A. M. & Georgiou, G. Structure and morphology of protein inclusion bodies in Escherichia coli. Biotechnology 9, 725–730 (1991).
  122. Herneke, A. et al. Protein nanofibrils for sustainable food—characterization and comparison of fibrils from a broad range of plant protein isolates. ACS Food Sci. Technol. 1, 854–864 (2021). · DOI
  123. Sunde, M. et al. Common core structure of amyloid fibrils by synchrotron X-ray diffraction. J. Mol. Biol. 273, 729–739 (1997). · DOI · Paper page
  124. Petkova, A. T. et al. A structural model for Alzheimer’s β-amyloid fibrils based on experimental constraints from solid state NMR. Proc. Natl Acad. Sci. USA 99, 16742–16747 (2002). · DOI · Paper page
  125. Wasmer, C. et al. Amyloid fibrils of the HET-s(218–289) prion form a β solenoid with a triangular hydrophobic core. Science 319, 1523–1526 (2008). · DOI · Paper page
  126. Scheres, S. H., Zhang, W., Falcon, B. & Goedert, M. Cryo-EM structures of tau filaments. Curr. Opin. Struct. Biol. 64, 17–25 (2020). · DOI · Paper page
  127. Geddes, A. J., Parker, K. D., Atkins, E. D. & Beighton, E. “Cross-β” conformation in proteins. J. Mol. Biol. 32, 343–358 (1968). · DOI · Paper page
  128. Yang, Y. et al. Cryo-EM structures of amyloid-β42 filaments from human brains. Science 375, 167–172 (2022). · DOI · Paper page
  129. Zhang, W. et al. Novel tau filament fold in corticobasal degeneration. Nature 580, 283–287 (2020). · DOI · Paper page
  130. Falcon, B. et al. Tau filaments from multiple cases of sporadic and inherited Alzheimer’s disease adopt a common fold. Acta Neuropathol. 136, 699–708 (2018). · DOI · Paper page
  131. Schweighauser, M. et al. Structures of α-synuclein filaments from multiple system atrophy. Nature 585, 464–469 (2020). · DOI · Paper page
  132. Yang, Y. et al. Structures of α-synuclein filaments from human brains with Lewy pathology. Nature 610, 791–795 (2022). · DOI · Paper page
  133. Zhao, K. et al. Parkinson’s disease-related phosphorylation at Tyr39 rearranges α-synuclein amyloid fibril structure revealed by cryo-EM. Proc. Natl Acad. Sci. USA 117, 20305–20315 (2020). · DOI · Paper page
  134. Guerrero-Ferreira, R., Kovacik, L., Ni, D. & Stahlberg, H. New insights on the structure of α-synuclein fibrils using cryo-electron microscopy. Curr. Opin. Neurobiol. 61, 89–95 (2020). · DOI
  135. Cao, Q., Boyer, D. R., Sawaya, M. R., Ge, P. & Eisenberg, D. S. Cryo-EM structures of four polymorphic TDP-43 amyloid cores. Nat. Struct. Mol. Biol. 26, 619–627 (2019). · DOI · Paper page
  136. Li, Q., Jaroniec, C. P. & Surewicz, W. K. Cryo-EM structure of disease-related prion fibrils provides insights into seeding barriers. Nat. Struct. Mol. Biol. 29, 962–965 (2022). · doi:10.1038/s41594-022-00833-4
  137. Cao, Q., Boyer, D. R., Sawaya, M. R., Ge, P. & Eisenberg, D. S. Cryo-EM structure and inhibitor design of human IAPP (amylin) fibrils. Nat. Struct. Mol. Biol. 27, 653–659 (2020). · DOI
  138. Gallardo, R. et al. Fibril structures of diabetes-related amylin variants reveal a basis for surface-templated assembly. Nat. Struct. Mol. Biol. 27, 1048–1056 (2020). · DOI
  139. Schmidt, M. et al. Cryo-EM structure of a transthyretin-derived amyloid fibril from a patient with hereditary ATTR amyloidosis. Nat. Commun. 10, 5008 (2019). · DOI · Paper page
  140. Liberta, F. et al. Cryo-EM fibril structures from systemic AA amyloidosis reveal the species complementarity of pathological amyloids. Nat. Commun. 10, 1104 (2019). · DOI
  141. Radamaker, L. et al. Cryo-EM structure of a light chain-derived amyloid fibril from a patient with systemic AL amyloidosis. Nat. Commun. 10, 1103 (2019). · DOI · Paper page
  142. Kaufman, S. K. et al. Tau prion strains dictate patterns of cell pathology, progression rate, and regional vulnerability in vivo. Neuron 92, 796–812 (2016). · DOI · Paper page
  143. Vaquer-Alicea, J., Diamond, M. I. & Joachimiak, L. A. Tau strains shape disease. Acta Neuropathol. 142, 57–71 (2021). · DOI
  144. Abskharon, R. et al. Cryo-EM structure of RNA-induced tau fibrils reveals a small C-terminal core that may nucleate fibril formation. Proc. Natl Acad. Sci. USA 119, e2119952119 (2022). · DOI
  145. Zhang, W. et al. Heparin-induced tau filaments are polymorphic and differ from those in Alzheimer’s and Pick’s diseases. eLife 8, e43584 (2019). · DOI · Paper page
  146. Tao, Y. et al. Heparin induces α-synuclein to form new fibril polymorphs with attenuated neuropathology. Nat. Commun. 13, 4226 (2022). · DOI
  147. Herrmann, U. S. et al. Structure-based drug design identifies polythiophenes as antiprion compounds. Sci. Transl. Med. 7, 299ra123 (2015). · DOI
  148. Heerde, T. et al. Cryo-EM demonstrates the in vitro proliferation of an ex vivo amyloid fibril morphology by seeding. Nat. Commun. 13, 85 (2022). · DOI
  149. Strohäker, T. et al. Structural heterogeneity of α-synuclein fibrils amplified from patient brain extracts. Nat. Commun. 10, 5535 (2019). · DOI · Paper page
  150. Lövestam, S. et al. Seeded assembly in vitro does not replicate the structures of α-synuclein filaments from multiple system atrophy. FEBS Open Bio 11, 999–1013 (2021). · DOI · Paper page
  151. Lövestam, S. et al. Assembly of recombinant tau into filaments identical to those of Alzheimer’s disease and chronic traumatic encephalopathy. eLife 11, e76494 (2022). · DOI · Paper page
  152. Al-Hilaly, Y. K. et al. Tau (297–391) forms filaments that structurally mimic the core of paired helical filaments in Alzheimer’s disease brain. FEBS Lett. 594, 944–950 (2020). · DOI
  153. Radamaker, L. et al. Cryo-EM reveals structural breaks in a patient-derived amyloid fibril from systemic AL amyloidosis. Nat. Commun. 12, 875 (2021). · DOI
  154. Arakhamia, T. et al. Posttranslational modifications mediate the structural diversity of tauopathy strains. Cell 180, 633–644.e12 (2020). · DOI · Paper page
  155. Louros, N. N. et al. Tracking the amyloidogenic core of IAPP amyloid fibrils: insights from micro-Raman spectroscopy. J. Struct. Biol. 199, 140–152 (2017). · DOI
  156. Ye, X., Hedenqvist, M. S., Langton, M. & Lendel, C. On the role of peptide hydrolysis for fibrillation kinetics and amyloid fibril morphology. RSC Adv. 8, 6915–6924 (2018). · DOI
  157. Louros, N. et al. Tau amyloid polymorphism is shaped by local structural propensities of its protein sequence. Preprint at bioRxiv https://doi.org/10.1101/2022.10.24.512987 (2022). · DOI
  158. Michaels, T. C. T. et al. Chemical kinetics for bridging molecular mechanisms and macroscopic measurements of amyloid fibril formation. Annu. Rev. Phys. Chem. 69, 273–298 (2018). · DOI · Paper page
  159. Michaels, T. C. T. et al. Fluctuations in the kinetics of linear protein self-assembly. Phys. Rev. Lett. 116, 258103 (2016). · doi:10.1103/physrevlett.116.258103
  160. Louros, N., Schymkowitz, J. & Rousseau, F. Heterotypic amyloid interactions: clues to polymorphic bias and selective cellular vulnerability? Curr. Opin. Struct. Biol. 72, 176–186 (2022). · DOI
  161. Juhl, D. W. et al. Conservation of the amyloid interactome across diverse fibrillar structures. Sci. Rep. 9, 3863 (2019). · DOI
  162. Chatterjee, D. et al. Co-aggregation and secondary nucleation in the life cycle of human prolactin/galanin functional amyloids. eLife 11, e73835 (2022). · DOI
  163. Pansieri, J. et al. Templating S100A9 amyloids on Aβ fibrillar surfaces revealed by charge detection mass spectrometry, microscopy, kinetic and microfluidic analyses. Chem. Sci. 11, 7031–7039 (2020). · DOI
  164. Linse, S. Monomer-dependent secondary nucleation in amyloid formation. Biophys. Rev. 9, 329–338 (2017). · DOI
  165. Törnquist, M. & Linse, S. Chiral selectivity of secondary nucleation in amyloid fibril propagation. Angew. Chem. Int. Ed. Engl. 60, 24008–24011 (2021). · DOI
  166. Thacker, D. et al. The role of fibril structure and surface hydrophobicity in secondary nucleation of amyloid fibrils. Proc. Natl Acad. Sci. USA 117, 25272–25283 (2020). · DOI
  167. Tian, Y. & Viles, J. H. pH dependence of amyloid-β fibril assembly kinetics: unravelling the microscopic molecular processes. Angew. Chem. Int. Ed. 61, e202210675 (2022). · DOI
  168. Kumari, P. et al. Structural insights into α-synuclein monomer–fibril interactions. Proc. Natl Acad. Sci. USA 118, e2012171118 (2021). · DOI
  169. Hadi Alijanvand, S., Peduzzo, A. & Buell, A. K. Secondary nucleation and the conservation of structural characteristics of amyloid fibril strains. Front. Mol. Biosci. https://doi.org/10.3389/fmolb.2021.669994 (2021). · DOI
  170. Brännström, K. et al. The properties of amyloid-β fibrils are determined by their path of formation. J. Mol. Biol. 430, 1940–1949 (2018). · DOI
  171. Sakalauskas, A., Ziaunys, M. & Smirnovas, V. Concentration-dependent polymorphism of insulin amyloid fibrils. PeerJ 7, e8208 (2019). · DOI
  172. Wördehoff, M. M. et al. Single fibril growth kinetics of α-synuclein. J. Mol. Biol. 427, 1428–1435 (2015). · DOI
  173. Sleutel, M. et al. Nucleation and growth of a bacterial functional amyloid at single-fiber resolution. Nat. Chem. Biol. 13, 902–908 (2017). · DOI
  174. Sun, Y. et al. Direct observation of competing prion protein fibril populations with distinct structures and kinetics. ACS Nano https://doi.org/10.1021/acsnano.2c12009 (2023). · DOI
  175. Pinotsi, D. et al. Direct observation of heterogeneous amyloid fibril growth kinetics via two-color super-resolution microscopy. Nano Lett. 14, 339–345 (2014). · DOI · Paper page
  176. Rodriguez, R. A., Chen, L. Y., Plascencia-Villa, G. & Perry, G. Thermodynamics of amyloid-β fibril elongation: atomistic details of the transition state. ACS Chem. Neurosci. 9, 783–789 (2018). · DOI
  177. Sasmal, S., Schwierz, N. & Head-Gordon, T. Mechanism of nucleation and growth of Aβ40 fibrils from all-atom and coarse-grained simulations. J. Phys. Chem. B 120, 12088–12097 (2016). · DOI
  178. Xu, Y. et al. Frustrated peptide chains at the fibril tip control the kinetics of growth of amyloid-β fibrils. Proc. Natl Acad. Sci. USA 118, e2110995118 (2021). · DOI
  179. Xu, Y. et al. Steady, symmetric, and reversible growth and dissolution of individual amyloid-β fibrils. ACS Chem. Neurosci. 10, 2967–2976 (2019). · DOI
  180. Nicoud, L., Lazzari, S., Balderas Barragán, D. & Morbidelli, M. Fragmentation of amyloid fibrils occurs in preferential positions depending on the environmental conditions. J. Phys. Chem. B 119, 4644–4652 (2015). · DOI
  181. Sanami, S., Purton, T. J., Smith, D. P., Tuite, M. F. & Xue, W. F. Comparative analysis of the relative fragmentation stabilities of polymorphic α-synuclein amyloid fibrils. Biomolecules https://doi.org/10.3390/biom12050630 (2022). · DOI
  182. Beal, D. M. et al. The division of amyloid fibrils: systematic comparison of fibril fragmentation stability by linking theory with experiments. iScience 23, 101512 (2020). · DOI · Paper page
  183. Zhang, X. et al. Correlation between cellular uptake and cytotoxicity of fragmented α-synuclein amyloid fibrils suggests intracellular basis for toxicity. ACS Chem. Neurosci. 11, 233–241 (2020). · DOI
  184. Morris, R. J. et al. Mechanistic and environmental control of the prevalence and lifetime of amyloid oligomers. Nat. Commun. 4, 1891 (2013). · DOI
  185. Konstantoulea, K. et al. Heterotypic amyloid β interactions facilitate amyloid assembly and modify amyloid structure. EMBO J. 41, e108591 (2022). · DOI
  186. Dear, A. J. et al. Kinetic diversity of amyloid oligomers. Proc. Natl Acad. Sci. USA 117, 12087–12094 (2020). · DOI · Paper page
  187. Michaels, T. C. T. et al. Dynamics of oligomer populations formed during the aggregation of Alzheimer’s Aβ42 peptide. Nat. Chem. 12, 445–451 (2020). · DOI · Paper page
  188. Crespo, R. et al. What can the kinetics of amyloid fibril formation tell about off-pathway aggregation? J. Biol. Chem. 291, 2018–2032 (2016). · DOI
  189. Hasecke, F. et al. Origin of metastable oligomers and their effects on amyloid fibril self-assembly. Chem. Sci. 9, 5937–5948 (2018). · DOI
  190. Hasecke, F. et al. Protofibril–fibril interactions inhibit amyloid fibril assembly by obstructing secondary nucleation. Angew. Chem. Int. Ed. 60, 3016–3021 (2021). · DOI
  191. Konno, H. et al. Dynamics of oligomer and amyloid fibril formation by yeast prion Sup35 observed by high-speed atomic force microscopy. Proc. Natl Acad. Sci. USA 117, 7831–7836 (2020). · DOI
  192. Kayed, R. & Lasagna-Reeves, C. A. Molecular mechanisms of amyloid oligomers toxicity. J. Alzheimers Dis. 33, S67–S78 (2013). · DOI · Paper page
  193. He, Y. et al. Amyloid β oligomers suppress excitatory transmitter release via presynaptic depletion of phosphatidylinositol-4,5-bisphosphate. Nat. Commun. 10, 1193 (2019). · DOI
  194. Cascella, R., Bigi, A., Cremades, N. & Cecchi, C. Effects of oligomer toxicity, fibril toxicity and fibril spreading in synucleinopathies. Cell. Mol. Life Sci. 79, 174 (2022). · DOI
  195. Wagner, J. et al. Medin co-aggregates with vascular amyloid-β in Alzheimer’s disease. Nature 612, 123–131 (2022). · DOI · Paper page
  196. Konstantoulea, K., Louros, N., Rousseau, F. & Schymkowitz, J. Heterotypic interactions in amyloid function and disease. FEBS J. 289, 2025–2046 (2022). · DOI
  197. Zhao, Y. et al. β2-Microglobulin coaggregates with Aβ and contributes to amyloid pathology and cognitive deficits in Alzheimer’s disease model mice. Nat. Neurosci. https://doi.org/10.1038/s41593-023-01352-1 (2023). · DOI
  198. Yu, A. et al. Tau protein aggregates inhibit the protein-folding and vesicular trafficking arms of the cellular proteostasis network. J. Biol. Chem. 294, 7917–7930 (2019). · DOI
  199. Engstrom, A. K. et al. The inhibition of LSD1 via sequestration contributes to tau-mediated neurodegeneration. Proc. Natl Acad. Sci. USA 117, 29133–29143 (2020). · DOI
  200. Lengyel, Z., Rufo, C. M. & Korendovych, I. V. Preparation and screening of catalytic amyloid assemblies. Methods Mol. Biol. 1777, 261–270 (2018). · doi:10.1007/978-1-4939-7811-3_16

200 of 351 shown

Cited by

See all 250

Metadata

Authors
Louros, N., Schymkowitz, J., & Rousseau, F.
Venue
Nature Reviews Molecular Cell Biology
Published
2023-09-08
Volume
24
Issue
12
Pages
912-933
ISSN
  • 1471-0072 (ISSN-L)
  • 1471-0080
OpenAlex
W4386532366
Cited by
250
References
53
FWCI
6.25
Type
journal article
Language
en
Open access
green
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mechanisms and pathology of protein misfolding and aggregation. https://app.cochat.ai/papers/10.1038/s41580-023-00647-2
The paper
Louros, N., Schymkowitz, J., & Rousseau, F. (2023). Mechanisms and pathology of protein misfolding and aggregation. Nature Reviews Molecular Cell Biology. https://doi.org/10.1038/s41580-023-00647-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.